These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 436334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of immune response in mice by navy bean lectin.
    Plouffe J, Lofgren R, Silva J, Fekety R, Goldstein I.
    J Clin Lab Immunol; 1980 May; 3(3):189-90. PubMed ID: 7420407
    [Abstract] [Full Text] [Related]

  • 4. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM, Litwin J, Bigel P, Oberling F, Mayer S.
    Acta Haematol Pol; 1977 May; 8(2):131-4. PubMed ID: 329629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S, Foggi CM, Serafini NA.
    Ann Ist Carlo Forlanini; 1968 May; 28(3):292-309. PubMed ID: 4903142
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M, Holm G, Mellstedt H, Johansson B, Killander D, Sunblad R, Söderberg G.
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [Abstract] [Full Text] [Related]

  • 9. Impaired lymphocyte function in untreated Hodgkin's disease.
    Levy R, Kaplan HS.
    N Engl J Med; 1974 Jan 24; 290(4):181-6. PubMed ID: 4203007
    [No Abstract] [Full Text] [Related]

  • 10. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
    Rocha B, Ferreira AA, Munn G, de Sousa M, Freitas AA.
    Clin Exp Immunol; 1982 May 24; 48(2):300-6. PubMed ID: 7105487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cluster of Hodgkin's lymphoma in residents near a non-operational petroleum refinery.
    Dahlgren J, Klein J, Takhar H.
    Toxicol Ind Health; 2008 Nov 24; 24(10):683-92. PubMed ID: 19141572
    [Abstract] [Full Text] [Related]

  • 16. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA.
    J Clin Invest; 1973 Dec 24; 52(12):3064-73. PubMed ID: 4201499
    [Abstract] [Full Text] [Related]

  • 17. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J, Lukásová M, Pinosová I.
    Neoplasma; 1973 Dec 24; 20(1):51-60. PubMed ID: 4702205
    [No Abstract] [Full Text] [Related]

  • 18. Re: "a cluster of Hodgkin's disease in a small community".
    Zack M, Heath CW, Isbister JL, Van Amburg G.
    Am J Epidemiol; 1979 May 24; 109(5):621-2. PubMed ID: 453183
    [No Abstract] [Full Text] [Related]

  • 19. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Amlot PL, Unger A.
    Clin Exp Immunol; 1976 Dec 24; 26(3):520-7. PubMed ID: 1009684
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD, Ewel C, Londono S, Metzger Z, Hoffeld JT, Oppenheim JJ.
    Clin Exp Immunol; 1981 Nov 24; 46(2):313-20. PubMed ID: 7337972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.